This is a Validated Antibody Database (VAD) review about human cytokeratin, based on 157 published articles (read how Labome selects the articles), using cytokeratin antibody in all methods. It is aimed to help Labome visitors find the most suited cytokeratin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cytokeratin synonym: CK1; EHK; EHK1; EPPK; K1; KRT1A; NEPPK

Knockout validation
Dako
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:200; loading ...; fig s4d
Dako cytokeratin antibody (Dako, Z0622) was used in western blot knockout validation on mouse samples at 1:200 (fig s4d). Hepatology (2019) ncbi
Leica Biosystems
monoclonal
  • immunohistochemistry knockout validation; mouse; 1:250; fig 1
  • western blot knockout validation; mouse; 1:250; fig 1
Leica Biosystems cytokeratin antibody (Leica, NCL-CK1) was used in immunohistochemistry knockout validation on mouse samples at 1:250 (fig 1) and in western blot knockout validation on mouse samples at 1:250 (fig 1). J Cell Sci (2012) ncbi
Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen cytokeratin antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen cytokeratin antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen cytokeratin antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen cytokeratin antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen cytokeratin antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen cytokeratin antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen cytokeratin antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen cytokeratin antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen cytokeratin antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (LHK1)
  • immunohistochemistry - paraffin section; human
In order to characterize multiple disease sites in a patient with widely metastatic melanoma who had a heterogeneous response, Invitrogen cytokeratin antibody (ThermoFisher, MA5-16032) was used in immunohistochemistry - paraffin section on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen cytokeratin antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen cytokeratin antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen cytokeratin antibody (Thermo Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen cytokeratin antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen cytokeratin antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen cytokeratin antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen cytokeratin antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen cytokeratin antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen cytokeratin antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen cytokeratin antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen cytokeratin antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen cytokeratin antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen cytokeratin antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen cytokeratin antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen cytokeratin antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen cytokeratin antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen cytokeratin antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen cytokeratin antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen cytokeratin antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen cytokeratin antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to describe two cases of trichilemmal carcinoma, Invitrogen cytokeratin antibody (Thermo Fisher Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:50. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen cytokeratin antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen cytokeratin antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen cytokeratin antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen cytokeratin antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen cytokeratin antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen cytokeratin antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen cytokeratin antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen cytokeratin antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen cytokeratin antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen cytokeratin antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:50; loading ...; fig 6f
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry on mouse samples at 1:50 (fig 6f). Cell Death Dis (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:75; loading ...; fig 2d
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry - paraffin section on mouse samples at 1:75 (fig 2d). Genes Dev (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; bovine; 1:10,000; loading ...; fig 9
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry on bovine samples at 1:10,000 (fig 9). Sci Rep (2021) ncbi
domestic rabbit monoclonal (EPR17744)
  • immunohistochemistry; human; 1:1000; loading ...; fig 1f
Abcam cytokeratin antibody (Abcam, ab185628) was used in immunohistochemistry on human samples at 1:1000 (fig 1f). elife (2020) ncbi
mouse monoclonal (80)
  • western blot; domestic rabbit; 1:5000; loading ...; fig 6b
Abcam cytokeratin antibody (Abcam, ab8068) was used in western blot on domestic rabbit samples at 1:5000 (fig 6b). Invest Ophthalmol Vis Sci (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...
Abcam cytokeratin antibody (Abcam, ab93652) was used in immunohistochemistry on mouse samples at 1:500. Cell Res (2020) ncbi
mouse monoclonal (34bE12)
  • immunohistochemistry; mouse; loading ...; fig s2e
Abcam cytokeratin antibody (Abcam, 34bE12) was used in immunohistochemistry on mouse samples (fig s2e). J Exp Med (2020) ncbi
domestic rabbit monoclonal (EPR17744)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 3c
  • western blot; mouse; 1:1000; loading ...; fig 4a
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam cytokeratin antibody (Abcam, ab185628) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 3c), in western blot on mouse samples at 1:1000 (fig 4a) and in western blot on human samples at 1:1000 (fig 4b). Biomol Ther (Seoul) (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry on mouse samples at 1:200. Nature (2019) ncbi
mouse monoclonal (80)
  • immunohistochemistry; mouse; 1:15; loading ...; fig s5b
Abcam cytokeratin antibody (Abcam, ab8068) was used in immunohistochemistry on mouse samples at 1:15 (fig s5b). Cell (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 2.5 ug/ml; fig 3
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry - frozen section on mouse samples at 2.5 ug/ml (fig 3). Nat Commun (2018) ncbi
mouse monoclonal (80)
  • immunohistochemistry; mouse; 1:200; loading ...; fig e1i
Abcam cytokeratin antibody (Abcam, ab8068) was used in immunohistochemistry on mouse samples at 1:200 (fig e1i). Nature (2018) ncbi
mouse monoclonal (34bE12)
  • flow cytometry; rat; loading ...; fig 1
Abcam cytokeratin antibody (Abcam, ab191208) was used in flow cytometry on rat samples (fig 1). Am J Transl Res (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; 1:100; loading ...; fig 5b
  • immunocytochemistry; human; 1:50; loading ...; fig 5a
Abcam cytokeratin antibody (Abcam, ab9377) was used in flow cytometry on human samples at 1:100 (fig 5b) and in immunocytochemistry on human samples at 1:50 (fig 5a). J Dermatol Sci (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunocytochemistry on human samples . Nature (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4b
In order to use CA9 and CD147 as capture antigens to isolate circulating tumor cells from patients with renal cell carcinoma, Abcam cytokeratin antibody (Abcam, ab9377) was used in immunocytochemistry on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (80)
  • immunohistochemistry - paraffin section; mouse; 1:10; loading ...; fig s4d
  • immunohistochemistry - paraffin section; human; 1:20; loading ...; fig s1a
In order to demonstrate that Musashi is crucial for pancreatic cancer progression, Abcam cytokeratin antibody (Abcam, ab8068) was used in immunohistochemistry - paraffin section on mouse samples at 1:10 (fig s4d) and in immunohistochemistry - paraffin section on human samples at 1:20 (fig s1a). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 3
  • immunohistochemistry - paraffin section; mouse; fig 3
In order to utilize a model of metastatic HPV+ oropharyngeal squamous cell carcinoma to displays heterogeneity in tumor metastasis, Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunohistochemistry - paraffin section on mouse samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (80)
  • immunohistochemistry - frozen section; human; 1:50; fig 2
Abcam cytokeratin antibody (abcam, ab8068) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2). J Clin Invest (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig s2
Abcam cytokeratin antibody (Abcam, ab9377) was used in immunocytochemistry on human samples (fig s2). Biomaterials (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; fig s2
In order to investigate the role of CD73 in endometrial cancer, Abcam cytokeratin antibody (Abcam, ab9377) was used in immunohistochemistry on human samples (fig s2). J Clin Invest (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 2Ei
Abcam cytokeratin antibody (Abcam, Ab9377) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 2Ei). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (80)
  • immunohistochemistry; human; 1:250; fig 3c
Abcam cytokeratin antibody (Abcam, ab8068) was used in immunohistochemistry on human samples at 1:250 (fig 3c). Tissue Eng Part C Methods (2015) ncbi
Novus Biologicals
mouse monoclonal (AE-1/AE-3)
  • immunocytochemistry; human; 1:200
Novus Biologicals cytokeratin antibody (Novus, NBP2-29429) was used in immunocytochemistry on human samples at 1:200. Cell Transplant (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (4D12B3)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 5
Santa Cruz Biotechnology cytokeratin antibody (Santacruz, sc-65999) was used in immunocytochemistry on mouse samples at 1:100 (fig 5). Sci Rep (2017) ncbi
mouse monoclonal (E-12)
  • immunohistochemistry; human; fig 1
In order to establish an in vitro system to study three-dimensional corneal differentiation, Santa Cruz Biotechnology cytokeratin antibody (Santa Cruz, sc-376224) was used in immunohistochemistry on human samples (fig 1). Nature (2014) ncbi
mouse monoclonal (AE13)
  • immunohistochemistry - paraffin section; mouse
In order to study the effects of conditional epidermal knockout of HDAC-1 and -2 on murine ectodermal organ morphogenesis, Santa Cruz Biotechnology cytokeratin antibody (Santa Cruz, SC-57012) was used in immunohistochemistry - paraffin section on mouse samples . J Invest Dermatol (2014) ncbi
OriGene
mouse monoclonal (AE1+AE3)
  • immunohistochemistry; human; tbl 1
OriGene cytokeratin antibody (OriGene, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Int J Clin Exp Pathol (2015) ncbi
Dako
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 2d
Dako cytokeratin antibody (Dako, M351501-2) was used in immunohistochemistry on human samples (fig 2d). Commun Biol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...
Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry on mouse samples at 1:200. Stem Cell Res Ther (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Dako cytokeratin antibody (DAKO, M351501-2) was used in immunohistochemistry - paraffin section on human samples (fig 3b). Cell Rep (2021) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4d
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Dako cytokeratin antibody (Agilent/Dako, z0622) was used in immunocytochemistry on human samples (fig 4d) and in immunohistochemistry - paraffin section on mouse samples (fig 4a). Mucosal Immunol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...
Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry on human samples at 1:100. Dev Cell (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 4b
Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry on mouse samples (fig 4b). Purinergic Signal (2019) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:200; loading ...; fig s4d
Dako cytokeratin antibody (Dako, Z0622) was used in western blot knockout validation on mouse samples at 1:200 (fig s4d). Hepatology (2019) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
Dako cytokeratin antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 6a). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 3a
Dako cytokeratin antibody (DAKO, Z0622) was used in immunohistochemistry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5a
Dako cytokeratin antibody (DAKO, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5a). Mol Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 4b
In order to establish an animal model to test how Zika virus crosses the placenta and causes congenital disease, Dako cytokeratin antibody (DAKO, Z0622) was used in immunohistochemistry on mouse samples at 1:200 (fig 4b). Nat Commun (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; rat; loading ...; fig 81
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako cytokeratin antibody (Dako, IR053) was used in immunohistochemistry on rat samples (fig 81). J Toxicol Pathol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:400; loading ...; fig 2
In order to analyze the importance of canonical Hedgehog signaling within the primary cilia+ liver progenitor cell population in humans, Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry on human samples at 1:400 (fig 2). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 7b
Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 7b). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:400; loading ...; fig 3b
Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry on human samples at 1:400 (fig 3b). Nat Med (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 2g
Dako cytokeratin antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:200 (fig 2g). Diagn Pathol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4
In order to use CLARITY and PACT to visualize the intestinal architecture, Dako cytokeratin antibody (Dako, Z0622) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:200; fig 3e
In order to develop methods to culture mesothelial cells isolated from the mouse omentum and characterize the cells, Dako cytokeratin antibody (Dako, Z0622) was used in immunocytochemistry on mouse samples at 1:200 (fig 3e). PLoS ONE (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig s6
In order to study the expression and functional role of stabilin-1 in breast cancer, Dako cytokeratin antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples (fig s6). Oncotarget (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; dogs; 1:1500; loading ...; fig 1d
In order to study canine prostate cancer cell line CHP-1 and co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein, Dako cytokeratin antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on dogs samples at 1:1500 (fig 1d). Vet Comp Oncol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:2; loading ...; fig 1a
In order to characterize circulating tumor cells and determine prognostic markers for pancreatic ductal adenocarcinoma, Dako cytokeratin antibody (Dako, IR053) was used in immunohistochemistry on human samples at 1:2 (fig 1a). Tumour Biol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; dogs; loading ...; fig 3a
Dako cytokeratin antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on dogs samples (fig 3a). Acta Vet Scand (2015) ncbi
Cell Signaling Technology
mouse monoclonal (C11)
  • western blot; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology cytokeratin antibody (CST, 4545) was used in western blot on human samples at 1:1000 (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (C11)
  • immunocytochemistry; mouse; 1:400; loading ...; fig s3
Cell Signaling Technology cytokeratin antibody (Cell Signaling, 4545) was used in immunocytochemistry on mouse samples at 1:400 (fig s3). Front Immunol (2021) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:2000; fig 3b
Cell Signaling Technology cytokeratin antibody (Cell Signaling Technology, 4545) was used in western blot on human samples at 1:2000 (fig 3b). Int J Mol Med (2019) ncbi
mouse monoclonal (C11)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology cytokeratin antibody (Cell Signaling, 4545) was used in western blot on mouse samples (fig 5b). Oncoimmunology (2019) ncbi
mouse monoclonal (C11)
  • immunocytochemistry; human; 1:300; loading ...; fig 3b
Cell Signaling Technology cytokeratin antibody (cell signalling, C11) was used in immunocytochemistry on human samples at 1:300 (fig 3b). Cell (2016) ncbi
mouse monoclonal (C11)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 6a
In order to propose that leukemia inhibitory factor signaling confers a dormancy phenotype in breast cancer cells that have disseminated to bone, Cell Signaling Technology cytokeratin antibody (Cell Signaling, 4545) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 6a). Nat Cell Biol (2016) ncbi
mouse monoclonal (C11)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
Cell Signaling Technology cytokeratin antibody (Cell signaling, 4545) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Endocrinology (2016) ncbi
mouse monoclonal (C11)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2b
Cell Signaling Technology cytokeratin antibody (Cell signaling, 4545) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2b). PLoS ONE (2015) ncbi
Ventana
mouse monoclonal (AE1/AE3/PCK26)
  • immunohistochemistry - paraffin section; human; loading ...; fig s18j
Ventana cytokeratin antibody (Ventana, AE1/AE3; PCK26) was used in immunohistochemistry - paraffin section on human samples (fig s18j). Science (2018) ncbi
Cell Marque
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:20; loading ...; fig 2c
In order to present a case of cellular spindle cell neoplasm with features of both cellular schwannoma and pseudoglandular schwannoma, Cell Marque cytokeratin antibody (Cell Marque, 34beta-E12) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 2c). Am J Dermatopathol (2016) ncbi
Leica Biosystems
mouse monoclonal (5D3)
  • immunohistochemistry; human; fig s7b
Leica Biosystems cytokeratin antibody (Leica, 5D3) was used in immunohistochemistry on human samples (fig s7b). Nat Commun (2021) ncbi
monoclonal
  • immunohistochemistry; human; loading ...; fig 4c
Leica Biosystems cytokeratin antibody (Leica Biosystems, AE1/AE3) was used in immunohistochemistry on human samples (fig 4c). Medicine (Baltimore) (2020) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3d
Leica Biosystems cytokeratin antibody (Novocastra Laboratories, NCL-5D3) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3d). J Vet Med Sci (2019) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
Leica Biosystems cytokeratin antibody (Leica, NCL-AE1-AE3) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry; human; loading ...
Leica Biosystems cytokeratin antibody (Novocastra, 5D3) was used in immunohistochemistry on human samples . Nature (2017) ncbi
monoclonal (AE1 and AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig S2E
Leica Biosystems cytokeratin antibody (Novocastra, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig S2E). Oncotarget (2016) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1A
  • immunocytochemistry; human; loading ...; fig S2B
Leica Biosystems cytokeratin antibody (Leica, 5D3) was used in immunohistochemistry - paraffin section on human samples (fig 1A) and in immunocytochemistry on human samples (fig S2B). Oncotarget (2016) ncbi
monoclonal
  • immunohistochemistry; human; 1:200
In order to characterize and present the features observed in sixteen cases of solid pseudopapillary neoplasm of the pancreas, Leica Biosystems cytokeratin antibody (Novocastra, NCL-L-AE1/AE3) was used in immunohistochemistry on human samples at 1:200. Kaohsiung J Med Sci (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:150; tbl 3
In order to investigate evidence for two distinct pathogenetic pathways by studing the squamous cell carcinoma of the oral cavity and cytokeratin and protein expression patterns, Leica Biosystems cytokeratin antibody (Novocastra, NCL-Ck1) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 3). Oncol Lett (2016) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 3
In order to characterize the spindle cell type of metaplastic breast carcinoma with myoepithelial features and report that this subtype exhibits a higher frequency of PIK3CA mutation than other types of metaplastic breast carcinoma, Leica Biosystems cytokeratin antibody (Leica Biosystems, 5D3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Virchows Arch (2016) ncbi
monoclonal
  • immunocytochemistry; human; fig 1
Leica Biosystems cytokeratin antibody (Novocastra Laboratories, AE1/AE3) was used in immunocytochemistry on human samples (fig 1). Sci Rep (2016) ncbi
monoclonal
  • immunocytochemistry; human; fig 1
Leica Biosystems cytokeratin antibody (Novocastra Laboratories, AE1/AE3) was used in immunocytochemistry on human samples (fig 1). Sci Rep (2016) ncbi
monoclonal
  • immunocytochemistry; human; fig 1
Leica Biosystems cytokeratin antibody (Novocastra Laboratories, AE1/AE3) was used in immunocytochemistry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2c
In order to present a case of cellular spindle cell neoplasm with features of both cellular schwannoma and pseudoglandular schwannoma, Leica Biosystems cytokeratin antibody (Leica, 5D3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2c). Am J Dermatopathol (2016) ncbi
monoclonal (AE1 and AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1
In order to suggest that locally synthesized C1q promotes tumor growth, Leica Biosystems cytokeratin antibody (Leica, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). Nat Commun (2016) ncbi
monoclonal
  • immunohistochemistry; human; 1:200; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Leica Biosystems cytokeratin antibody (Leica, AE1/AE3) was used in immunohistochemistry on human samples at 1:200 (fig 6). Diagn Pathol (2015) ncbi
monoclonal
  • immunohistochemistry; human; 1:200; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Leica Biosystems cytokeratin antibody (Leica, AE1/AE3) was used in immunohistochemistry on human samples at 1:200 (fig 6). Diagn Pathol (2015) ncbi
monoclonal
  • immunohistochemistry; human; 1:200; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Leica Biosystems cytokeratin antibody (Leica, AE1/AE3) was used in immunohistochemistry on human samples at 1:200 (fig 6). Diagn Pathol (2015) ncbi
monoclonal
  • western blot; human; 1:50; fig 4
Leica Biosystems cytokeratin antibody (Novocastra, NCL-CK1) was used in western blot on human samples at 1:50 (fig 4). PLoS ONE (2015) ncbi
monoclonal
  • immunocytochemistry; anapsid reptiles; 1:100
Leica Biosystems cytokeratin antibody (Novocastra, NCL-L-5D3) was used in immunocytochemistry on anapsid reptiles samples at 1:100. Environ Sci Technol (2014) ncbi
monoclonal
  • western blot; human; 1:200
In order to investigate the role of delta-opioid receptor in human keratinocytes, Leica Biosystems cytokeratin antibody (Novocastra, NCL-CK1) was used in western blot on human samples at 1:200. J Invest Dermatol (2015) ncbi
monoclonal
  • immunohistochemistry knockout validation; mouse; 1:250; fig 1
  • western blot knockout validation; mouse; 1:250; fig 1
Leica Biosystems cytokeratin antibody (Leica, NCL-CK1) was used in immunohistochemistry knockout validation on mouse samples at 1:250 (fig 1) and in western blot knockout validation on mouse samples at 1:250 (fig 1). J Cell Sci (2012) ncbi
BD Biosciences
monoclonal (CAM5.2)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 2b
BD Biosciences cytokeratin antibody (BD, CAM5.2) was used in immunocytochemistry on human samples at 10 ug/ml (fig 2b). BMC Cancer (2020) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 2b
BD Biosciences cytokeratin antibody (BD, CAM5.2) was used in immunocytochemistry on human samples at 10 ug/ml (fig 2b). BMC Cancer (2020) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; fig 4, 5
BD Biosciences cytokeratin antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
monoclonal (CAM5.2)
  • immunocytochemistry; human; fig 4, 5
BD Biosciences cytokeratin antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
monoclonal (CAM5.2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4c
BD Biosciences cytokeratin antibody (BD Biosciences, 345779) was used in immunohistochemistry - paraffin section on human samples (fig 4c). J Histochem Cytochem (2018) ncbi
mouse monoclonal (CAM 5.2)
  • flow cytometry; human; 15 ug/ml; loading ...
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BD Biosciences cytokeratin antibody (BD Biosciences, 347653) was used in flow cytometry on human samples at 15 ug/ml. Cell Death Dis (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; fig s9b
BD Biosciences cytokeratin antibody (BD Bioscience, Cam5.2) was used in immunohistochemistry - paraffin section on human samples (fig s9b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; dogs
  • immunohistochemistry; dogs; fig 84
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences cytokeratin antibody (BD Biosciences, 349205) was used in immunohistochemistry - paraffin section on dogs samples and in immunohistochemistry on dogs samples (fig 84). J Toxicol Pathol (2017) ncbi
mouse monoclonal (CAM 5.2)
  • flow cytometry; crab eating macaque; fig 4a
In order to ask if small particle aerosols of virus would penetrate the lower respiratory tract and blanket alveoli where target cells reside, BD Biosciences cytokeratin antibody (BD Biosciences, CAM5.2) was used in flow cytometry on crab eating macaque samples (fig 4a). J Immunol (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; loading ...; fig 5a
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, BD Biosciences cytokeratin antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 5a). Cancer Res (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; 1:600; loading ...; fig 4
In order to develop methods to capture circulating tumor cells using transparent nanomaterials and quantum dots-based multiplexed imaging, BD Biosciences cytokeratin antibody (BD Biosciences, BD-349205) was used in immunocytochemistry on human samples at 1:600 (fig 4). J Cancer (2016) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
BD Biosciences cytokeratin antibody (BD Biosciences, CAM 5.2) was used in immunohistochemistry on human samples . Virchows Arch (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
BD Biosciences cytokeratin antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; fig 3
BD Biosciences cytokeratin antibody (BD Biosciences, Cam5.2) was used in immunohistochemistry - paraffin section on human samples (fig 3). Nature (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human
In order to study the role of neural stem cells in the pathogenesis of CNS lymphomas, BD Biosciences cytokeratin antibody (Becton Dickinson, 349205) was used in immunohistochemistry - paraffin section on human samples . Springerplus (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:10
In order to describe a case of marginal zone lymphoma with extensive emperipolesis, BD Biosciences cytokeratin antibody (BD Biosciences, CAM5.2) was used in immunohistochemistry - paraffin section on human samples at 1:10. Cytopathology (2016) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:1
BD Biosciences cytokeratin antibody (Becton Dickinson Immunocytometry Systems, Cam5.2) was used in immunohistochemistry - paraffin section on human samples at 1:1. World J Gastroenterol (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:20
BD Biosciences cytokeratin antibody (BD, Cam 5.2) was used in immunohistochemistry - paraffin section on human samples at 1:20. Endocr Pathol (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human
BD Biosciences cytokeratin antibody (Beckton Dickinson, CAM5.2) was used in immunocytochemistry on human samples . J Cancer (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human
BD Biosciences cytokeratin antibody (Becton-Dickinson, CAM5.2) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; dogs
BD Biosciences cytokeratin antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on dogs samples . J Comp Pathol (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, BD Biosciences cytokeratin antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
In order to investigate the thymus development, BD Biosciences cytokeratin antibody (Becton, CAM 5.2) was used in immunohistochemistry on human samples . Development (2013) ncbi
MilliporeSigma
mouse monoclonal (C-11)
  • western blot; rat; 1:1000; loading ...; fig 2
MilliporeSigma cytokeratin antibody (Sigma-Aldrich, P2871) was used in western blot on rat samples at 1:1000 (fig 2). J Mol Med (Berl) (2021) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5p
MilliporeSigma cytokeratin antibody (Sigma, P2871) was used in immunohistochemistry on mouse samples at 1:50 (fig 5p). Dis Model Mech (2021) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; human; 1:100; loading ...; fig 6a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, MilliporeSigma cytokeratin antibody (Sigma, C-11) was used in immunocytochemistry on human samples at 1:100 (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; mouse; fig s1
MilliporeSigma cytokeratin antibody (Sigma, P2871) was used in immunohistochemistry - paraffin section on mouse samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (C-11)
  • western blot; rat
In order to characterize two new cell lines with the potential to be used to study portal (myo)fibroblasts, MilliporeSigma cytokeratin antibody (Sigma-Aldrich, clone C-11) was used in western blot on rat samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
MilliporeSigma cytokeratin antibody (Sigma-Aldrich, C-11) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100. Biomaterials (2014) ncbi
Articles Reviewed
  1. Chen Y, Lian N, Chen S, Xiao T, Ke Y, Zhang Y, et al. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022;13:841 pubmed publisher
  2. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  3. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  4. Strait A, Woolaver R, Hall S, Young C, Karam S, Jimeno A, et al. Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma. Commun Biol. 2021;4:1005 pubmed publisher
  5. Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N, et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049 pubmed publisher
  6. Goonetilleke M, Kuk N, Correia J, Hodge A, Moore G, Gantier M, et al. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells. Stem Cell Res Ther. 2021;12:429 pubmed publisher
  7. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  8. Zhang Y, Hu M, Yang F, Zhang Y, Ma S, Zhang D, et al. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance. J Mol Med (Berl). 2021;99:1427-1446 pubmed publisher
  9. Shelton W, Thomas S, Alexander H, Thomes C, Conway D, Dubash A. Desmoglein-2 harnesses a PDZ-GEF2/Rap1 signaling axis to control cell spreading and focal adhesions independent of cell-cell adhesion. Sci Rep. 2021;11:13295 pubmed publisher
  10. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  11. Parodi B, Sanna A, Cedola A, Uccelli A, Kerlero de Rosbo N. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response. Front Immunol. 2021;12:655212 pubmed publisher
  12. Seavey C, Pobbati A, Hallett A, Ma S, Reynolds J, Kanai R, et al. WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis. Genes Dev. 2021;35:512-527 pubmed publisher
  13. Niborski L, Paces Fessy M, Ricci P, Bourgeois A, Magalh xe3 es P, Kuzma Kuzniarska M, et al. Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model. Dis Model Mech. 2021;14: pubmed publisher
  14. Krausová A, Buresova P, Sarnova L, Oyman Eyrilmez G, Skarda J, Wohl P, et al. Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunol. 2021;14:691-702 pubmed publisher
  15. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  16. Lyon P, Suomi V, Jakeman P, Campo L, Coussios C, Carlisle R. Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometry. Sci Rep. 2021;11:4404 pubmed publisher
  17. Jones I, Novikova L, Wiberg M, Carlsson L, Novikov L. Human Embryonic Stem Cell-derived Neural Crest Cells Promote Sprouting and Motor Recovery Following Spinal Cord Injury in Adult Rats. Cell Transplant. 2021;30:963689720988245 pubmed publisher
  18. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  19. Pan L, Lemieux M, Thomas T, Rogers J, Lipper C, Lee W, et al. IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. elife. 2020;9: pubmed publisher
  20. Wang Y, Gao G, Wu Y, Wang Y, Wu X, Zhou Q. S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway. Invest Ophthalmol Vis Sci. 2020;61:19 pubmed publisher
  21. Ortiz Otero N, Marshall J, Lash B, King M. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873 pubmed publisher
  22. Dabelsteen S, Pallesen E, Marinova I, Nielsen M, Adamopoulou M, Rømer T, et al. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model. Dev Cell. 2020;54:669-684.e7 pubmed publisher
  23. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  24. Luo P, Yan H, Chen X, Zhang Y, Zhao Z, Cao J, et al. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide. Cell Res. 2020;30:779-793 pubmed publisher
  25. Hermanova I, Z iga Garc a P, Caro Maldonado A, Fernandez Ruiz S, Salvador F, Mart n Mart n N, et al. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer. J Exp Med. 2020;217: pubmed publisher
  26. Li D, Zhu R, Zhou L, Zhong D. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors. Medicine (Baltimore). 2020;99:e19090 pubmed publisher
  27. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  28. Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2019;: pubmed publisher
  29. Jeong H, Lim K, Goldenring J, Nam K. Rab25 Deficiency Perturbs Epidermal Differentiation and Skin Barrier Function in Mice. Biomol Ther (Seoul). 2019;27:553-561 pubmed publisher
  30. Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439-444 pubmed publisher
  31. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  32. Rothweiler S, Feldbrügge L, Jiang Z, Csizmadia E, Longhi M, Vaid K, et al. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis. Purinergic Signal. 2019;15:375-385 pubmed publisher
  33. Ajina R, Zamalin D, Zuo A, Moussa M, Catalfamo M, Jablonski S, et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology. 2019;8:e1577127 pubmed publisher
  34. Lytle N, Ferguson L, Rajbhandari N, Gilroy K, Fox R, Deshpande A, et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019;177:572-586.e22 pubmed publisher
  35. Lee S, Ji H, Baek S, Lee A, Kim M, Park S, et al. Feline-type cystic basal cell tumor filled with abundant melanin pigment-rich fluid in a dog. J Vet Med Sci. 2019;81:269-273 pubmed publisher
  36. Russell J, Lu W, Okabe H, Abrams M, Oertel M, Poddar M, et al. Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes. Hepatology. 2019;69:742-759 pubmed publisher
  37. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  38. Cuchet Lourenço D, Eletto D, Wu C, Plagnol V, Papapietro O, CURTIS J, et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science. 2018;361:810-813 pubmed publisher
  39. Kim J, Villadsen R. Expression of Luminal Progenitor Marker CD117 in the Human Breast Gland. J Histochem Cytochem. 2018;66:879-888 pubmed publisher
  40. Liakath Ali K, Mills E, Sequeira I, Lichtenberger B, Pisco A, Sipilä K, et al. An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis. Nature. 2018;556:376-380 pubmed publisher
  41. Lin H, Wei S, Hurt E, Green M, Zhao L, Vatan L, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J Clin Invest. 2018;128:805-815 pubmed publisher
  42. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  43. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  44. Ran H, Kong S, Zhang S, Cheng J, Zhou C, He B, et al. Nuclear Shp2 directs normal embryo implantation via facilitating the ERα tyrosine phosphorylation by the Src kinase. Proc Natl Acad Sci U S A. 2017;114:4816-4821 pubmed publisher
  45. Shin J, Choi D, Sohn K, Kim J, Im M, Lee Y, et al. Targeted deletion of Crif1 in mouse epidermis impairs skin homeostasis and hair morphogenesis. Sci Rep. 2017;7:44828 pubmed publisher
  46. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  47. Moore L, England A, Ehrlich B, Rimm D. Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival. Mol Cancer Res. 2017;15:942-952 pubmed publisher
  48. Fumagalli A, Drost J, Suijkerbuijk S, van Boxtel R, de Ligt J, Offerhaus G, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114:E2357-E2364 pubmed publisher
  49. Braxton D, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette J, et al. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". Hum Pathol. 2017;62:232-241 pubmed publisher
  50. Vermillion M, Lei J, Shabi Y, Baxter V, Crilly N, McLane M, et al. Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat Commun. 2017;8:14575 pubmed publisher
  51. Scarpa A, Chang D, Nones K, Corbo V, Patch A, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65-71 pubmed publisher
  52. Ascierto M, Makohon Moore A, Lipson E, Taube J, McMiller T, Berger A, et al. Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy. Clin Cancer Res. 2017;23:3168-3180 pubmed publisher
  53. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  54. Grzelak C, Sigglekow N, Tirnitz Parker J, Hamson E, Warren A, Maneck B, et al. Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease. PLoS ONE. 2017;12:e0171480 pubmed publisher
  55. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  56. Zhu J, Wang P, Yu Z, Lai W, Cao Y, Huang P, et al. Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells. Am J Transl Res. 2016;8:5569-5579 pubmed
  57. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed publisher
  58. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed publisher
  59. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  60. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  61. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed publisher
  62. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed publisher
  63. Lin Y, Mori E, Kato M, Xiang S, Wu L, Kwon I, et al. Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers. Cell. 2016;167:789-802.e12 pubmed publisher
  64. Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294-1302 pubmed publisher
  65. Yu L, Li J, Xu S, Navia Miranda M, Wang G, Duan Y. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Diagn Pathol. 2016;11:98 pubmed
  66. Neckel P, Mattheus U, Hirt B, Just L, Mack A. Large-scale tissue clearing (PACT): Technical evaluation and new perspectives in immunofluorescence, histology, and ultrastructure. Sci Rep. 2016;6:34331 pubmed publisher
  67. Johnson R, Finger E, Olcina M, Vilalta M, Aguilera T, Miao Y, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18:1078-1089 pubmed publisher
  68. Ni J, Wang N, Gao L, Li L, Zheng S, Liu Y, et al. The effect of the NMDA receptor-dependent signaling pathway on cell morphology and melanosome transfer in melanocytes. J Dermatol Sci. 2016;84:296-304 pubmed publisher
  69. Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102-106 pubmed publisher
  70. Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. 2016;7:59877-59891 pubmed publisher
  71. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  72. Ugras N, Yerci O, Coşkun S, Ocakoglu G, Sarkut P, Dündar H. Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas. Kaohsiung J Med Sci. 2016;32:356-61 pubmed publisher
  73. Dauleh S, Santeramo I, Fielding C, Ward K, Herrmann A, Murray P, et al. Characterisation of Cultured Mesothelial Cells Derived from the Murine Adult Omentum. PLoS ONE. 2016;11:e0158997 pubmed publisher
  74. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  75. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  76. Fox R, Lytle N, Jaquish D, Park F, Ito T, Bajaj J, et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature. 2016;534:407-411 pubmed publisher
  77. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  78. Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, et al. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer. Virchows Arch. 2016;469:191-201 pubmed publisher
  79. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  80. Antony N, McDougall A, Mantamadiotis T, Cole T, Bird A. Creb1 regulates late stage mammalian lung development via respiratory epithelial and mesenchymal-independent mechanisms. Sci Rep. 2016;6:25569 pubmed publisher
  81. Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016;7:31097-110 pubmed publisher
  82. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed publisher
  83. Vermeer D, Coppock J, Zeng E, Lee K, Spanos W, Onken M, et al. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7:24194-207 pubmed publisher
  84. Deborde S, Omelchenko T, Lyubchik A, Zhou Y, He S, McNamara W, et al. Schwann cells induce cancer cell dispersion and invasion. J Clin Invest. 2016;126:1538-54 pubmed publisher
  85. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  86. Sundarkrishnan L, Bradish J, Oliai B, Hosler G. Cutaneous Cellular Pseudoglandular Schwannoma: An Unusual Histopathologic Variant. Am J Dermatopathol. 2016;38:315-8 pubmed publisher
  87. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  88. Crowley C, Klanrit P, Butler C, Varanou A, Platé M, Hynds R, et al. Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold. Biomaterials. 2016;83:283-93 pubmed publisher
  89. Azakami D, Nakahira R, Kato Y, Michishita M, Onozawa E, Bonkobara M, et al. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α. Vet Comp Oncol. 2017;15:557-562 pubmed publisher
  90. Chen Y, Cheng B, He Z, Wang S, Wang Z, Sun M, et al. Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging. J Cancer. 2016;7:69-79 pubmed publisher
  91. Kulemann B, Liss A, Warshaw A, Seifert S, Bronsert P, Glatz T, et al. KRAS mutations in pancreatic circulating tumor cells: a pilot study. Tumour Biol. 2016;37:7547-54 pubmed publisher
  92. Bowser J, Blackburn M, Shipley G, Molina J, Dunner K, Broaddus R. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest. 2016;126:220-38 pubmed publisher
  93. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  94. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  95. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  96. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  97. Judd L, Heine R, Menheniott T, Buzzelli J, O Brien Simpson N, Pavlic D, et al. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice. Am J Physiol Gastrointest Liver Physiol. 2016;310:G13-25 pubmed publisher
  98. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed publisher
  99. Singh S, Chand H, Gundavarapu S, Saeed A, Langley R, Tesfaigzi Y, et al. HIF-1α Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice. PLoS ONE. 2015;10:e0137757 pubmed publisher
  100. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  101. Paiva B, Silva J, Ocarino N, Oliveira C, Assis W, Serakides R. A rare case of endometrioma in a bitch. Acta Vet Scand. 2015;57:31 pubmed publisher
  102. Hampel U, Schröder A, Mitchell T, Brown S, Snikeris P, Garreis F, et al. Serum-induced keratinization processes in an immortalized human meibomian gland epithelial cell line. PLoS ONE. 2015;10:e0128096 pubmed publisher
  103. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  104. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  105. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  106. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  107. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  108. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  109. Drost J, van Jaarsveld R, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43-7 pubmed publisher
  110. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  111. Fausther M, Goree J, Lavoie Ã, Graham A, Sévigny J, Dranoff J. Establishment and characterization of rat portal myofibroblast cell lines. PLoS ONE. 2015;10:e0121161 pubmed publisher
  112. Xiu Y, Jiang L, Liu W. Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature. Int J Clin Exp Pathol. 2015;8:983-8 pubmed
  113. Campbell J, Miller D, Cundiff D, Feng Q, Litofsky N. Neural stem/progenitor cells react to non-glial cns neoplasms. Springerplus. 2015;4:53 pubmed publisher
  114. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  115. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed publisher
  116. Yamada S, Nabeshima A, Noguchi H, Nawata A, Nishii H, Guo X, et al. Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. World J Gastroenterol. 2015;21:1349-56 pubmed publisher
  117. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  118. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  119. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  120. Webb S, Zychowski G, Bauman S, Higgins B, Raudsepp T, Gollahon L, et al. Establishment, characterization, and toxicological application of loggerhead sea turtle (Caretta caretta) primary skin fibroblast cell cultures. Environ Sci Technol. 2014;48:14728-37 pubmed publisher
  121. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  122. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  123. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  124. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  125. Sajin M, Luchian M, Hodorogea Prisăcaru A, Dumitru A, Pătraşcu O, Costache D, et al. Trichilemmal carcinoma - a rare cutaneous malignancy: report of two cases. Rom J Morphol Embryol. 2014;55:687-91 pubmed
  126. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  127. Neumann C, Bigliardi Qi M, Widmann C, Bigliardi P. The δ-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3. J Invest Dermatol. 2015;135:471-480 pubmed publisher
  128. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  129. Ouyang H, Xue Y, Lin Y, Zhang X, Xi L, Patel S, et al. WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis. Nature. 2014;511:358-61 pubmed publisher
  130. Khmaladze A, Kuo S, Kim R, Matthews R, Marcelo C, Feinberg S, et al. Human oral mucosa tissue-engineered constructs monitored by Raman fiber-optic probe. Tissue Eng Part C Methods. 2015;21:46-51 pubmed publisher
  131. Woodward W, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, et al. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer. 2014;5:360-7 pubmed publisher
  132. Liu Z, Yu N, Holz F, Yang F, Stanzel B. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837-50 pubmed publisher
  133. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  134. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  135. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed publisher
  136. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  137. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  138. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  139. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  140. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  141. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  142. Hughes M, Jiang T, Lin S, Leung Y, Kobielak K, Widelitz R, et al. Disrupted ectodermal organ morphogenesis in mice with a conditional histone deacetylase 1, 2 deletion in the epidermis. J Invest Dermatol. 2014;134:24-32 pubmed publisher
  143. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  144. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed publisher
  145. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  146. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  147. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  148. Wallace L, Roberts Thompson L, Reichelt J. Deletion of K1/K10 does not impair epidermal stratification but affects desmosomal structure and nuclear integrity. J Cell Sci. 2012;125:1750-8 pubmed publisher
  149. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  150. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  151. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  152. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  153. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  154. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  155. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  156. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  157. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed